Dr. Suguni Aushadhi Loku Galappaththy, MD

Dr. Loku Galappaththy practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Loku Galappaththy's NPI, 1356831226, was assigned on May 15, 2018. Dr. Loku Galappaththy holds Ohio license 35.151935.

Dr. Loku Galappaththy's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Loku Galappaththy's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Loku Galappaththy is also affiliated with Fairview Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Loku Galappaththy to 1 more hospital and 2 clinical labs, each named with a free account. Dr. Loku Galappaththy's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Loku Galappaththy practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Loku Galappaththy's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Loku Galappaththy is licensed in Ohio.

CMS data shows 268 Medicare services from Dr. Loku Galappaththy across 3 procedure codes in 2022. Medicare paid $23,947 for them. Every service was in a facility, such as a hospital, rather than an office.

Across all payers, Dmand AI patient panel data puts Dr. Loku Galappaththy's median patient age at 54, with 73% women.

In 2024, Dr. Loku Galappaththy wrote 54 Medicare Part D claims for 24 patients. 98% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $402 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Loku Galappaththy for performance year 2024, reported through an alternative payment model (APM). Dr. Loku Galappaththy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Loku Galappaththy as offering telehealth.

Dmand AI links 2 papers to Dr. Loku Galappaththy in 2019. 2019 was the busiest year, with 2. Dr. Loku Galappaththy has published most often in Cureus. Dr. Loku Galappaththy's most frequent co-authors are Mouhanna Khaled Mahmoud Abu Ghanimeh, MD, Brandon D. Barthel, MD and Nedaa M. Husainat, MD.

CMS Open Payments shows 3 general payments to Dr. Loku Galappaththy from 3 drug and device companies from 2022 to 2023. Food and beverage make up the largest share, 54% of the total. Janssen Pharmaceuticals, Inc paid the most, $99.